<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05059288</url>
  </required_header>
  <id_info>
    <org_study_id>CIA 291</org_study_id>
    <nct_id>NCT05059288</nct_id>
  </id_info>
  <brief_title>NIV Mask Assessment of Usability and Performance</brief_title>
  <official_title>Usability and Performance of a Non-invasive Ventilation Mask. A Prospective Cohort.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Fisher and Paykel Healthcare</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Fisher and Paykel Healthcare</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Assessment of usability, perceived comfort and performance of a NIV mask in the hospital&#xD;
      environment.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      50 participants admitted for NIV therapy will have the investigation mask fitted. The doctors&#xD;
      and nurses assigned to the participants care will complete a subjective evaluation on how the&#xD;
      mask performs compared to the standard of care mask. Some therapy settings and demographics&#xD;
      will be recorded.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">October 28, 2021</start_date>
  <completion_date type="Anticipated">December 31, 2022</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Other</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Perceived mask performance</measure>
    <time_frame>During the intervention</time_frame>
    <description>Three point visual analogue scale on preference 1 = Worse, 2 = Same, 3 = Better</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">50</enrollment>
  <condition>Respiratory Failure</condition>
  <arm_group>
    <arm_group_label>Investigation Mask</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Non invasive ventilation mask</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Investigational Non Invasive Ventilation Mask</intervention_name>
    <description>Oronasal non invasive ventilation mask</description>
    <arm_group_label>Investigation Mask</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Admitted and indicated for non invasive ventilation therapy&#xD;
&#xD;
          -  Assessed for capacity to consent and consent process documented&#xD;
&#xD;
          -  Fits the investigation mask&#xD;
&#xD;
          -  Aged 18 year or older&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
        - Contraindicated for non invasive ventilation&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Robert Martynoga</last_name>
    <role>Principal Investigator</role>
    <affiliation>Waikato Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Jessica R Fogarin</last_name>
    <phone>095740100</phone>
    <email>jessica.fogarin@fphcare.co.nz</email>
  </overall_contact>
  <verification_date>September 2021</verification_date>
  <study_first_submitted>September 6, 2021</study_first_submitted>
  <study_first_submitted_qc>September 19, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">September 28, 2021</study_first_posted>
  <last_update_submitted>September 19, 2021</last_update_submitted>
  <last_update_submitted_qc>September 19, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">September 28, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Respiratory Insufficiency</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

